• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

灭活脊髓灰质炎疫苗:基于微载体Vero细胞培养的工业化生产。

Inactivated polio vaccine: industrial production from micro-carrier Vero cells culture.

作者信息

Montagnon B J

出版信息

Trop Geogr Med. 1985 Sep;37(3):S40-1.

PMID:4071633
Abstract

In 1980, we presented our preliminary results of large-scale production of Inactivated Polio-Vaccine (IPV). The virus was produced by Vero cells culture grown on micro-carrier in 150 litre tanks; now we produce the poliovirus in 1000 litre tanks. All the tests certifying the 'Cell Bank' have been passed; the quality of purification procedure was demonstrated; additional clinical studies were done; this new reassessed IPV was licensed in France in July 1982.

摘要

1980年,我们公布了大规模生产灭活脊髓灰质炎疫苗(IPV)的初步结果。该病毒是通过在150升罐体中的微载体上培养的Vero细胞生产的;现在我们在1000升罐体中生产脊髓灰质炎病毒。所有认证“细胞库”的测试均已通过;纯化程序的质量得到了证明;还进行了额外的临床研究;这种重新评估的新型IPV于1982年7月在法国获得许可。

相似文献

1
Inactivated polio vaccine: industrial production from micro-carrier Vero cells culture.灭活脊髓灰质炎疫苗:基于微载体Vero细胞培养的工业化生产。
Trop Geogr Med. 1985 Sep;37(3):S40-1.
2
Polio and rabies vaccines produced in continuous cell lines: a reality for Vero cell line.在连续传代细胞系中生产的脊髓灰质炎疫苗和狂犬病疫苗:Vero细胞系的实际应用
Dev Biol Stand. 1989;70:27-47.
3
Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV.使用减毒 Sabin 脊灰病毒株进行灭活脊灰疫苗开发以实现技术转让,从 Salk-IPV 转向 Sabin-IPV。
Vaccine. 2011 Sep 22;29(41):7188-96. doi: 10.1016/j.vaccine.2011.05.079. Epub 2011 Jun 7.
4
The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine.用于病毒疫苗生产的微载体培养中VERO细胞的大规模培养。灭活脊髓灰质炎疫苗的初步结果。
Dev Biol Stand. 1981;47:55-64.
5
Production, testing and perspectives of IPV and IPV combination vaccines: GSK biologicals' view.灭活脊髓灰质炎疫苗及灭活脊髓灰质炎疫苗联合疫苗的生产、测试与前景:葛兰素史克生物制品公司观点
Biologicals. 2006 Jun;34(2):163-6. doi: 10.1016/j.biologicals.2006.03.010. Epub 2006 May 8.
6
Technology transfer of Sabin-IPV to new developing country markets.将萨宾灭活脊髓灰质炎疫苗技术转让至新的发展中国家市场。
Biologicals. 2006 Jun;34(2):155-8. doi: 10.1016/j.biologicals.2006.02.011. Epub 2006 May 2.
7
Development of inactivated poliovirus vaccine derived from Sabin strains.源自萨宾株的灭活脊髓灰质炎病毒疫苗的研发。
Biologicals. 2006 Jun;34(2):151-4. doi: 10.1016/j.biologicals.2006.02.010. Epub 2006 May 5.
8
Thousand litre scale microcarrier culture of Vero cells for killed polio virus vaccine. Promising results.用于灭活脊髓灰质炎病毒疫苗的Vero细胞千升规模微载体培养。结果令人鼓舞。
Dev Biol Stand. 1983;55:37-42.
9
Industrial-scale production of inactivated poliovirus vaccine prepared by culture of Vero cells on microcarrier.通过在微载体上培养Vero细胞制备灭活脊髓灰质炎病毒疫苗的工业化规模生产。
Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S341-4. doi: 10.1093/clinids/6.supplement_2.s341.
10
CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.CpG寡脱氧核苷酸是一种由脊髓灰质炎病毒的萨宾株生产的灭活脊髓灰质炎疫苗的有效佐剂。
Vaccine. 2009 Nov 5;27(47):6558-63. doi: 10.1016/j.vaccine.2009.08.047. Epub 2009 Sep 1.

引用本文的文献

1
Construction of Vero cell-adapted rabies vaccine strain by five amino acid substitutions in HEP-Flury strain.构建通过在HEP-Flury 株中五个氨基酸替换适应 Vero 细胞的狂犬病疫苗株。
Sci Rep. 2024 May 31;14(1):12559. doi: 10.1038/s41598-024-63337-9.